Suppr超能文献

使用纯化蛋白衍生物(PPD)注射治疗免疫功能低下患者的多发性顽固性疣:病例报告

Treatment of Multiple Recalcitrant Warts in an Immunocompromised Patient Using Purified Protein Derivative (PPD) Injection: A Case Report.

作者信息

Alkhayal Fares A, Alyousef Loujain A

机构信息

Dermatology and Dermatologic Surgery Department, Prince Sultan Military Medical City, Riyadh, Saudi Arabia.

Dermatology Department, Security Forces Hospital, Riyadh, Saudi Arabia.

出版信息

Am J Case Rep. 2025 Aug 12;26:e947367. doi: 10.12659/AJCR.947367.

Abstract

BACKGROUND Warts are common cutaneous viral infections primarily caused by human papillomavirus (HPV). They occur in all age groups, with immunocompromised individuals being particularly susceptible. Patients with compromised immune systems, such as those with acquired immunodeficiency syndrome (AIDS), organ transplant recipients, and individuals on immunosuppressive therapies, are at a higher risk of developing warts. These patients are also more likely to have severe and persistent warts, often necessitating multiple treatment approaches. Conventional therapies such as cryotherapy, laser ablation, and topical treatments often yield suboptimal results in this population due to their compromised immune response. Although intralesional immunotherapy, such as purified protein derivative (PPD), has been shown to stimulate a systemic immune response and facilitate wart clearance, its use in immunosuppressed individuals remains under-reported and under-utilized in clinical practice. CASE REPORT We report the case of a 70-year-old woman with a history of immunosuppression who presented with multiple recalcitrant warts on her left hand. Due to the persistence of lesions despite previous treatments, she received PPD injection sessions in a single lesion. Remarkably, all of her warts regressed completely within 6 weeks, with no recurrence observed during follow-up. No adverse effects were reported, highlighting the safety of this approach. CONCLUSIONS This case underscores the potential of PPD immunotherapy as an effective, safe, and well-tolerated treatment modality for warts in immunocompromised patients. Given its immunostimulatory properties and ability to induce systemic clearance, PPD should be considered a valuable alternative for managing refractory warts in this high-risk population. Further studies are warranted to establish standardized protocols and optimize its clinical application.

摘要

背景

疣是常见的皮肤病毒感染,主要由人乳头瘤病毒(HPV)引起。各年龄组均可发生,免疫功能低下的个体尤其易感。免疫系统受损的患者,如获得性免疫缺陷综合征(AIDS)患者、器官移植受者以及接受免疫抑制治疗的个体,患疣的风险更高。这些患者也更易出现严重且持续的疣,常常需要多种治疗方法。由于免疫反应受损,冷冻疗法、激光消融和局部治疗等传统疗法在这类人群中往往效果欠佳。尽管病灶内免疫疗法,如纯化蛋白衍生物(PPD),已被证明可刺激全身免疫反应并促进疣的清除,但在免疫抑制个体中的应用在临床实践中仍报道不足且未得到充分利用。病例报告:我们报告一例70岁有免疫抑制病史的女性患者,其左手出现多个顽固性疣。尽管先前进行了治疗,但病灶持续存在,她在单个病灶接受了PPD注射治疗。值得注意的是,她所有的疣在6周内完全消退,随访期间未观察到复发。未报告不良反应,突出了该方法的安全性。结论:本病例强调了PPD免疫疗法作为免疫功能低下患者疣的一种有效、安全且耐受性良好的治疗方式的潜力。鉴于其免疫刺激特性和诱导全身清除的能力,PPD应被视为该高危人群中治疗难治性疣的一种有价值的替代方法。有必要进一步开展研究以建立标准化方案并优化其临床应用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验